• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Evolution in the treatment of multiple myeloma and impact on dialysis independence: data from a French cohort from 1999 to 2014.

作者信息

Laforet M, Jourde-Chiche N, Haddad F, Sallee M, Stoppa A M, Brunet P, Dussol B, Burtey S, Gondouin B

机构信息

Centre de Nephrologie et Transplantation Rénale, Hopital La Conception, Marseille, France.

Vascular Research Center of Marseille, Faculté de Pharmacie, Aix-Marseille Université, Marseille, France.

出版信息

Blood Cancer J. 2016 Mar 25;6(3):e409. doi: 10.1038/bcj.2016.17.

DOI:10.1038/bcj.2016.17
PMID:27015286
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4817100/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0130/4817100/f1d3ea739c30/bcj201617f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0130/4817100/f1d3ea739c30/bcj201617f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0130/4817100/f1d3ea739c30/bcj201617f1.jpg

相似文献

1
Evolution in the treatment of multiple myeloma and impact on dialysis independence: data from a French cohort from 1999 to 2014.多发性骨髓瘤治疗的演变及其对透析独立性的影响：来自法国1999年至2014年队列的数据。
Blood Cancer J. 2016 Mar 25;6(3):e409. doi: 10.1038/bcj.2016.17.
2
The impact of the introduction of bortezomib on dialysis independence in multiple myeloma patients with renal impairment: a nationwide Dutch population-based study.硼替佐米的引入对肾功能损害的多发性骨髓瘤患者透析独立性的影响：一项基于荷兰全国人口的研究。
Haematologica. 2018 Jul;103(7):e311-e314. doi: 10.3324/haematol.2017.184754. Epub 2018 Mar 15.
3
Multiple myeloma in Korea: past, present, and future perspectives. Experience of the Korean Multiple Myeloma Working Party.韩国的多发性骨髓瘤：过去、现在及未来展望。韩国多发性骨髓瘤工作组的经验
Int J Hematol. 2010 Jul;92(1):52-7. doi: 10.1007/s12185-010-0617-6. Epub 2010 Jun 11.
4
A population-based study of the impact of dialysis on mortality in multiple myeloma.一项基于人群的关于透析对多发性骨髓瘤死亡率影响的研究。
Br J Haematol. 2018 Feb;180(4):588-591. doi: 10.1111/bjh.14394. Epub 2016 Oct 21.
5
[Current approaches to treating of patients with multiple myeloma with renal failure: Questions and proofs].
Ter Arkh. 2017;89(7):112-117. doi: 10.17116/terarkh2017897112-117.
6
[Update in multiple myeloma: international criteria for treatment response and renal complications].[多发性骨髓瘤的最新进展：治疗反应及肾脏并发症的国际标准]
Rev Med Interne. 2009 Dec;30(12):1080-3. doi: 10.1016/j.revmed.2009.09.003. Epub 2009 Oct 14.
7
Renal failure and multiple myeloma: pathogenesis and treatment of renal failure and management of underlying myeloma.肾衰竭与多发性骨髓瘤：肾衰竭的发病机制与治疗以及潜在骨髓瘤的管理
Blood Rev. 1999 Jun;13(2):79-90. doi: 10.1016/s0268-960x(99)90014-0.
8
Renal failure in multiple myeloma: a medical emergency.多发性骨髓瘤导致的肾衰竭：医疗急症。
Bone Marrow Transplant. 2011 Jun;46(6):771-83. doi: 10.1038/bmt.2011.8. Epub 2011 Feb 21.
9
Effects of hemodialysis on profound memory deficits in renal insufficiency due to multiple myeloma: a case study.
Appl Neuropsychol. 2009;16(1):76-82. doi: 10.1080/09084280802623031.
10
Multiple myeloma: managing a complex blood cancer.多发性骨髓瘤：应对一种复杂的血癌。
Br J Nurs. 2016 Sep 8;25(16):S18-28. doi: 10.12968/bjon.2016.25.S18.

引用本文的文献

1
Clinicopathological characteristics and prognosis in patients with monoclonal gammopathy and renal damage in central China: a multicenter retrospective cohort study.中国中部地区伴肾功能损害的单克隆丙种球蛋白病患者的临床病理特征及预后：一项多中心回顾性队列研究。
Sci Rep. 2024 Apr 1;14(1):7667. doi: 10.1038/s41598-024-58467-z.
2
Impact of dialysis dependence on survival for multiple myeloma with renal impairment: a multicenter study in China.透析依赖对合并肾功能损害的多发性骨髓瘤患者生存的影响：一项中国多中心研究
Am J Cancer Res. 2023 Apr 15;13(4):1571-1581. eCollection 2023.
3
-.

本文引用的文献

1
Trends in Survival and Renal Recovery in Patients with Multiple Myeloma or Light-Chain Amyloidosis on Chronic Dialysis.接受长期透析的多发性骨髓瘤或轻链淀粉样变性患者的生存及肾脏恢复趋势
Clin J Am Soc Nephrol. 2016 Mar 7;11(3):431-41. doi: 10.2215/CJN.06290615. Epub 2016 Jan 4.
2
Optimizing the treatment of patients with multiple myeloma and renal impairment.优化多发性骨髓瘤合并肾功能损害患者的治疗。
Clin Lymphoma Myeloma Leuk. 2015 Apr;15(4):187-98. doi: 10.1016/j.clml.2014.09.012. Epub 2014 Oct 5.
3
International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma.
-.
Clin Kidney J. 2019 Oct 30;14(1):156-166. doi: 10.1093/ckj/sfz128. eCollection 2021 Jan.
4
Association between serum erythropoietin levels and renal reversibility in patients with renal impairment from multiple myeloma.血清促红细胞生成素水平与多发性骨髓瘤致肾功能损害患者肾脏逆转的相关性。
Cancer Med. 2020 Jun;9(12):4460-4466. doi: 10.1002/cam4.3050. Epub 2020 Apr 20.
5
Impact of hemodialysis on the prognosis of multiple myeloma: A nationwide population-based study and single-institute analysis.血液透析对多发性骨髓瘤预后的影响：一项基于全国人口的研究及单机构分析。
Oncol Lett. 2018 Aug;16(2):1991-2002. doi: 10.3892/ol.2018.8857. Epub 2018 May 31.
6
Myeloma light chain cast nephropathy, a review.多发性骨髓瘤轻链 casts 肾病，一篇综述。
J Nephrol. 2019 Apr;32(2):189-198. doi: 10.1007/s40620-018-0492-4. Epub 2018 May 5.
7
The impact of the introduction of bortezomib on dialysis independence in multiple myeloma patients with renal impairment: a nationwide Dutch population-based study.硼替佐米的引入对肾功能损害的多发性骨髓瘤患者透析独立性的影响：一项基于荷兰全国人口的研究。
Haematologica. 2018 Jul;103(7):e311-e314. doi: 10.3324/haematol.2017.184754. Epub 2018 Mar 15.
8
Outcomes of newly diagnosed myeloma patients requiring dialysis: renal recovery, importance of rapid response and survival benefit.新诊断的需要透析的骨髓瘤患者的预后：肾脏恢复、快速反应的重要性及生存获益
Blood Cancer J. 2017 Jun 16;7(6):e571. doi: 10.1038/bcj.2017.49.
国际骨髓瘤工作组更新了多发性骨髓瘤的诊断标准。
Lancet Oncol. 2014 Nov;15(12):e538-48. doi: 10.1016/S1470-2045(14)70442-5. Epub 2014 Oct 26.
4
Severe acute kidney injury and multiple myeloma: evaluation of kidney and patient prognostic factors.严重急性肾损伤与多发性骨髓瘤：肾脏及患者预后因素评估
Eur J Intern Med. 2014 Sep;25(7):652-6. doi: 10.1016/j.ejim.2014.06.023. Epub 2014 Jul 15.
5
Significant improvement in the survival of patients with multiple myeloma presenting with severe renal impairment after the introduction of novel agents.新型药物问世后，严重肾功能损害的多发性骨髓瘤患者的生存率显著提高。
Ann Oncol. 2014 Jan;25(1):195-200. doi: 10.1093/annonc/mdt483.
6
Optimizing treatment strategies in myeloma cast nephropathy: rationale for a randomized prospective trial.优化骨髓瘤管型肾病的治疗策略：一项随机前瞻性试验的原理。
Adv Chronic Kidney Dis. 2012 Sep;19(5):333-41. doi: 10.1053/j.ackd.2012.07.003.
7
Early reduction of serum-free light chains associates with renal recovery in myeloma kidney.血清游离轻链的早期降低与骨髓瘤肾的肾功能恢复相关。
J Am Soc Nephrol. 2011 Jun;22(6):1129-36. doi: 10.1681/ASN.2010080857. Epub 2011 Apr 21.
8
Treatment of patients with relapsed/refractory multiple myeloma with lenalidomide and dexamethasone with or without bortezomib: prospective evaluation of the impact of cytogenetic abnormalities and of previous therapies.来那度胺和地塞米松联合或不联合硼替佐米治疗复发/难治性多发性骨髓瘤患者：细胞遗传学异常和既往治疗影响的前瞻性评估。
Leukemia. 2010 Oct;24(10):1769-78. doi: 10.1038/leu.2010.175. Epub 2010 Aug 26.
9
Presentation and survival of patients with severe acute kidney injury and multiple myeloma: a 20-year experience from a single centre.严重急性肾损伤和多发性骨髓瘤患者的表现和生存：单中心 20 年经验。
Nephrol Dial Transplant. 2010 Feb;25(2):419-26. doi: 10.1093/ndt/gfp488. Epub 2009 Sep 19.
10
European trial of free light chain removal by extended haemodialysis in cast nephropathy (EuLITE): a randomised control trial.欧洲铸型肾病延长血液透析清除游离轻链试验（EuLITE）：一项随机对照试验。
Trials. 2008 Sep 28;9:55. doi: 10.1186/1745-6215-9-55.